LOS ANGELES, CA--(Marketwire - November 15, 2007) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process®, a powerful pathogen inactivation method designed to substantially reduce all types of pathogens in biological products, today announced that revenues, for the nine month period ending September 30, 2007, increased 56% to a record $0.76 million from $0.49 million in the same period of 2006.
